Analysts/Institutional Investor Meet/Con. Call Updates

October 28, 2026 To, To, The Listing Department, The Listing Department BSE Limited, National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Bandra (East), Mumbai – 400001 Mumbai – 400051 Scrip code: 544889 Symbol: SYMBIOTEC Sub.: Intimation of earnings conference call for analysts and investors Ref.: Regulation 30 read with Para A of Schedule III and Regulation 46(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”); Dear Sir / Madam, Pursuant to above referred Listing Regulations, we enclose herewith the details of the ‘Earnings Conference Call / Analysts Meet’ to discuss the financial performance and business updates for the quarter and half year ended September 30, 2026 (Q2FY27). The Earnings Conference Call is scheduled to be held on Friday, November 06, 2026 at 09:30 A.M. IST, through virtual/audio conference call. The call is being hosted by Avendus Spark. The detailed invitation containing the conference call particulars is enclosed herewith. The schedule of the aforesaid call is subject to change due to exigencies, if any. Kindly note that no unpublished price sensitive information shall be shared during the call. The above information is also being made available on the website of the Company at investor.symbiotec.com Thanking You, Sincerely, for Symbiotec Pharmalab Limited Salil Jain Company Secretary and Compliance Officer Membership No. A41610 Encl: As above Registered Office & Works: Symbiotec Pharmalab Limited (Formerly known as Symbiotec Pharmalab Pvt. Ltd.) 385/2, Pigdamber, Rau, Mhow, Indore - 453331, Madhya Pradesh, India Tel. No.: +91-731-6676405-406 Fax: +91-731-4201222, Email ID : symbiotec@symbiotec.com, Website : www.symbiotec.com CIN: U24232MP2002PLC015293 Symbiotec Pharmalab Ltd – Q2 & H1FY27 Earnings Call Avendus Spark is pleased to invite you to the Q2 & H1FY27 Earnings Call of Symbiotec Pharmalab Ltd Symbiotec Pharmalab Ltd would be represented by Mr. Anil Satwani – Chairman & Managing Director Mr. Raghavender Ramachandran – Chief Financial Officer Conference Call Details Date: Friday, 6 November 2026 | Time 09:30 AM (IST) Express Join with DiamondPass™ No Wait Time https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=4849428&linkSecurityString=2ae4a932e4 Universal Dial In +91 22 6280 1230 / +91 22 7115 8131 UK + 08081011573 USA + 18667462133 Singapore + 8001012045 Hong Kong + 800964448 For further information please contact DR HARITH AHAMED, Executive Director - Equity Research Spark Institutional Equities Private Limited | +91 87544 94133 | harith.a@avendusspark.com | www.avendusspark.com